{
    "2019-04-27": [
        [
            {
                "time": "2023-10-16",
                "original_text": "Why AbbVie Is in Better Shape Than You Might Think",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Better Shape",
                        "Might Think"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs",
                "features": {
                    "keywords": [
                        "Week Ahead",
                        "Biotech",
                        "Conferences",
                        "PDUFA Dates",
                        "Clinical Trial Readouts",
                        "IPOs"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "Biosimilar competition to AbbVieâ€™s Humira is eroding profits, but company says it has confidence in pipeline",
                "features": {
                    "keywords": [
                        "Biosimilar",
                        "Competition",
                        "AbbVie",
                        "Humira",
                        "Eroding Profits",
                        "Confidence",
                        "Pipeline"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}